tiprankstipranks
Cresco Labs (CRLBF)
OTHER OTC:CRLBF
US Market
Holding CRLBF?
Track your performance easily

Cresco Labs (CRLBF) Earnings Dates, Call Summary & Reports

2,192 Followers

Earnings Data

Report Date
Mar 13, 2025
TBA Not Confirmed
Period Ending
2024 (Q4)
Consensus EPS Forecast
>-0.01
Last Year’s EPS
0.01
Same Quarter Last Year
Moderate Buy
Based on 2 Analysts Ratings
---

Earnings Call Summary

Earnings Call Date:May 29, 2019
|
% Change Since: -29.69%
|
Next Earnings Date:Dec 10, 2018
Earnings Call Sentiment|Neutral
Cresco Labs demonstrated strong financial performance with record operating cash flow and strategic growth in key markets like Ohio. Despite these achievements, challenges such as revenue decline in Illinois, price compression, and the disappointing outcome in Florida's Amendment 3 vote were noted. The company remains optimistic about future growth opportunities and federal reform.
Company Guidance
During the Cresco Labs Third Quarter 2024 Earnings Conference Call, the company reported strong financial performance with $180 million in revenue, a 53% adjusted gross profit margin, and a 29% adjusted EBITDA margin. Year-over-year, Cresco Labs improved its adjusted gross margin by 250 basis points and adjusted EBITDA margin by 275 basis points. The company achieved $51 million in adjusted EBITDA, marking a 5% improvement compared to the previous year, and generated $49 million in operating cash flow for the quarter, totaling $103 million year-to-date, which is $41 million more than the first nine months of last year. Cresco Labs maintained leading branded market share positions in several states, including Illinois, Pennsylvania, and Massachusetts, and experienced significant growth in Ohio, achieving a top-three branded market share position with an increase of 220 basis points year-over-year. Despite facing some revenue challenges due to price compression and retail fragmentation, Cresco Labs remains committed to strategic investments in core markets and new growth opportunities, expecting Q4 revenue to decline mid-single digits due to market conditions.
Strong Financial Performance
Cresco Labs reported $180 million in revenue with a 53% adjusted gross profit margin and a 29% adjusted EBITDA margin. Adjusted gross margin increased by 250 basis points, and EBITDA margin by 275 basis points year-over-year.
Record Operating Cash Flow
The company delivered $49 million in operating cash flow in the quarter and $103 million year-to-date, which is $41 million more than the previous year despite slightly lower revenue.
Strategic Market Position in Ohio
Cresco Labs achieved a top three branded market share position in Ohio, up 220 basis points year-over-year, due to improved efficiencies and strong branding.
Wholesale Excellence
Cresco Labs holds the number one overall share positions in branded products in Illinois, Pennsylvania, and Massachusetts, while reducing cost of goods sold by 11%.
Retail Platform Growth
Improved retail fair share to 1.4 times on average across markets, the highest in Cresco Labs' history, with a 76% sales increase year-over-year after converting Pennsylvania dispensaries to the Sunnyside platform.
---

Cresco Labs (CRLBF) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

CRLBF Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Dec 10, 20182018 (Q3)
- / -
-0.339
May 29, 20192018 (Q4)
- / -0.05
May 29, 20192019 (Q1)
- / -
Aug 21, 20192019 (Q2)
- / -0.04
Nov 26, 20192019 (Q3)
- / -0.02
May 28, 20202020 (Q1)
- / -
-0.035
May 28, 20202019 (Q4)
- / -0.04
-0.0528.00% (+0.01)
Aug 20, 20202020 (Q2)
- / -0.01
-0.04573.33% (+0.03)
Nov 18, 20202020 (Q3)
- / 0.01
-0.02165.00% (+0.03)
Mar 25, 20212020 (Q4)
- / -0.06
-0.1560.00% (+0.09)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---

CRLBF Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Nov 08, 2024$1.28$1.24-3.13%
Aug 08, 2024$1.45$1.62+11.72%
May 15, 2024$2.02$2.09+3.47%
Mar 13, 2024$1.56$1.79+14.74%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---

FAQ

When does Cresco Labs (CRLBF) report earnings?
Cresco Labs (CRLBF) is schdueled to report earning on Mar 13, 2025, TBA Not Confirmed.
    What is Cresco Labs (CRLBF) earnings time?
    Cresco Labs (CRLBF) earnings time is at Mar 13, 2025, TBA Not Confirmed.
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is CRLBF EPS forecast?
          CRLBF EPS forecast for the fiscal quarter 2024 (Q4) is >-0.01.
            ---
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis